Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Adult Patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in First Complete Remission (CR1): Favorable Outcome of Patients with Negative Minimal Residual Disease (MRD) Status at Transplant. a Report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT)

Blood (2017) 130 (Supplement 1): 669.

https://doi.org/10.1182/blood.V130.Suppl_1.669.669

Published: 2017

Journal Articles

Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT

Regis Peffault de Latour, Myriam Labopin, Jan Cornelissen, MD PhD, Lars Vindelov, MD, Didier Blaise, MD, Noel Milpied, MD, Anne Huyn, MD, Charles F. Craddock, BM, MRCP, MRCPath, Nigel Russel, Vladimir Koza, MD, Bruno Lioure, MD, Richard Schouten, BSc, Dolores Caballero, MD, Jean-Yves Cahn, MD, Nathalie Fegueux, MD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 961.

https://doi.org/10.1182/blood.V120.21.961.961

Published: 2012

Journal Articles

Intravenous Busulfan (IV Bu)-Based Conditioning Regimen Before Allogeneic Stem Cell Transplantation (allo-SCT) for Adults with Acute Lymphoid Leukemia (ALL): A Aurvey From the Acute Leukemia Working Party of EBMT

Mohamad Mohty, Myriam Labopin, MD, MS, Miguel A. Sanz, MD, PhD, Rose-Marie Hamljadi, Vladimir Koza, MD, William Arcese, MD, Antonio Campos, Noel-Jean Milpied, MD, Arnon Nagler, MD

Blood (2011) 118 (21): 3005.

https://doi.org/10.1182/blood.V118.21.3005.3005

Published: 2011

Journal Articles

Five-Color Multiplex Real-Time PCR Technology to Detect Over 75 Recurrent Chromosomal Abnormalities in Acute Myeloid Leukemia; Benefits for Minimal Residual Disease Detection

Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, David Warren Hardekopf, Tereza Jancuskova, Lucie Krutilkova, Michal Karas, Vladimir Koza, MD, Jan Vydra, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova

Blood (2011) 118 (21): 2526.

https://doi.org/10.1182/blood.V118.21.2526.2526

Published: 2011

Journal Articles

High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) Has a Significant but Transient Impact on Quality of Life: Lessons From the Chronic Lymphocytic Leukemia (CLL) ASCT Study by the CLL Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Liesbeth C. de Wreede, PhD, Maggie Watson, Donald Milligan, MD, MBChB, Mauricette Michallet, Peter Dreger, Prof. Dr. med., Marleen van Os, Claire E. Dearden, Catherine Cordonnier, Michel Leporrier, MD, Vladimir Koza, MD, Janis Homewood, Bernadette Corront, MD, Gabriela M. Baerlocher, MD, Wolfgang Herr, Dietger Niederwieser, MD, Laurent Sutton, Theo M. de Witte, MD, Johannes Schetelig, MD

Blood (2011) 118 (21): 1989.

https://doi.org/10.1182/blood.V118.21.1989.1989

Published: 2011

Journal Articles

Identification of Novel Molecular Markers for the Follow-up of Minimal Residual Disease in Hematooncological Disorders

David Warren Hardekopf, Tereza Jancuskova, Marie Jarosova, Lucie Krutilkova, Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, Jan Vydra, Tomas Kozak, MD, PhD, Michal Karas, Vladimir Koza, MD, Alzbeta Zavrelova, MD, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova

Blood (2011) 118 (21): 4905.

https://doi.org/10.1182/blood.V118.21.4905.4905

Published: 2011

Journal Articles

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Blood (2011) 117 (23): 6375–6382.

https://doi.org/10.1182/blood-2011-01-329821

Published: 2011

Includes: Supplemental data

Journal Articles

High Impact of Human Leukocyte Antigen Matching On Overall Survival and Transplant Related Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Long-Term Study From the EBMT Registry.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Stéphane Morisset, MSc, Dietger Niederwieser, MD, Vladimir Koza, MD, Tapani Ruutu, MD, Nigel H. Russell, MD, Leo Verdonck, MD, Donald Milligan, MD, Nathalie Dhedin, MD, Tomas Kozak, Marc Boogaerts, MD, PhD, Juergen Finke, MD, Valérie Dubois, MD, Anja van Biezen, Ronald Brand, Theo de Witte, MD, Peter Dreger, MD

Blood (2009) 114 (22): 2286.

https://doi.org/10.1182/blood.V114.22.2286.2286

Published: 2009

Journal Articles

Autologous and Allogeneic Stem Cell Transplantation for Richter's Transformation: A Retrospective Analysis From the Chronic Leukaemia Working Party and Lymphoma Working Party of the EBMT.

Kate Cwynarski, MD, PhD, Anja van Biezen, Ronald Brand, Marijke Scholten, Bernd Metzner, Mohamad Mohty, MD, PhD, Vladimir Koza, MD, Maija Itala-Remes, Fabio Ciceri, MD, Arnon Nagler, MD, T. M. de Witte, Anna Sureda, MD, PhD, Peter Dreger

Blood (2009) 114 (22): 3360.

https://doi.org/10.1182/blood.V114.22.3360.3360

Published: 2009

Journal Articles

Patients with Mature T-Cell Lymphoma Show High Relapse Rates after High Dose Therapy and Autologous Stem Cell Transplantation

Maike Nickelsen, MD, Carmen Canals, Sr., MD, Norbert Schmitz, MD, PhD, Charalampia Kyriakou, MD, PhD, Monika Engelhardt, MD, PhD, Thomas Relander, MD, Werner Linkesch, MD, PhD, Vladimir Koza, MD, Giovanna Meloni, MD, Armando Lopez-Guillermo, MD, Karel Indrac, MD, Dolores Caballero, MD, Hannes Wandt, MD, PhD, Niklas Theorin, MD, Bertram Glass, MD, PhD, Anna Sureda, MD, PhD

Blood (2008) 112 (11): 774.

https://doi.org/10.1182/blood.V112.11.774.774

Published: 2008

Journal Articles

Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Benefit from the Newer Drugs Used in the Relapsed Setting.

Blood (2008) 112 (11): 3331.

https://doi.org/10.1182/blood.V112.11.3331.3331

Published: 2008

Journal Articles

Correlation of Cytokines Levels and Adhesion Molecules Expression with Stem Cell Mobilization Efficacy in Healthy Donors

Daniel Lysák, MD, Alexandra Jungová, MD, Jindra Vrzalová, M.Sc., Luboš Holubec, MD, PhD, Vladimir Koza, MD

Blood (2008) 112 (11): 3466.

https://doi.org/10.1182/blood.V112.11.3466.3466

Published: 2008

Journal Articles

The Reduced Intensity Cvd Regimen: A Good Option with Well Balanced Efficacy/Toxicity Ratio for Elderly Patients with Poor Status Performance

Roman Hajek, Lenka Zahradova, Evzen Gregora, Miroslava Schutzova, Vladimir Koza, Petr Pavlicek, Ludek Pour, Marta Krejci, Viera Sandecka, Andrea Krivanova, Mohammed Al Sahmani, Dana Kralova, Zdenek Adam

Blood (2008) 112 (11): 3699.

https://doi.org/10.1182/blood.V112.11.3699.3699

Published: 2008

Journal Articles

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

Mauricette Michallet, MD, PhD, Quoc Hung Le, MD, Peter Dreger, Mohamad Sobh, PhD, Dietger Niederwieser, MD, Vladimir Koza, MD, Tapani Ruutu, Nigel H. Russell, MD, Leo Verdonck, Donald Milligan, MD, MBChB, Nathalie Dhedin, Tomas Kozak, MD, PhD, Marc Boogaerts, MD, PhD, Juergen Finke, Nathalie Tedone, Anja Van Biezen, Ronald Brand, Theo de Witte on behalfhe European Group for Blood Marrow Transplantation

Blood (2008) 112 (11): 566.

https://doi.org/10.1182/blood.V112.11.566.566

Published: 2008

Journal Articles

A Randomized Prospective Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors

Blood (2008) 112 (11): 57.

https://doi.org/10.1182/blood.V112.11.57.57

Published: 2008

Journal Articles

A Prospective Study on the Feasibility of Related and Unrelated Donor Search and Hematopoietic Cell Transplantation for Adults with Acute Leukemia at 31 European Transplant Centers

Blood (2008) 112 (11): 2385.

https://doi.org/10.1182/blood.V112.11.2385.2385

Published: 2008

Journal Articles

Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.

Blood (2007) 110 (11): 531.

https://doi.org/10.1182/blood.V110.11.531.531

Published: 2007

Journal Articles

Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation

Blood (1998) 92 (10): 3599–3604.

https://doi.org/10.1182/blood.V92.10.3599

Published: 1998

NARROW

Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT

Intravenous Busulfan (IV Bu)-Based Conditioning Regimen Before Allogeneic Stem Cell Transplantation (allo-SCT) for Adults with Acute Lymphoid Leukemia (ALL): A Aurvey From the Acute Leukemia Working Party of EBMT

Five-Color Multiplex Real-Time PCR Technology to Detect Over 75 Recurrent Chromosomal Abnormalities in Acute Myeloid Leukemia; Benefits for Minimal Residual Disease Detection

Identification of Novel Molecular Markers for the Follow-up of Minimal Residual Disease in Hematooncological Disorders

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

High Impact of Human Leukocyte Antigen Matching On Overall Survival and Transplant Related Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Long-Term Study From the EBMT Registry.

Autologous and Allogeneic Stem Cell Transplantation for Richter's Transformation: A Retrospective Analysis From the Chronic Leukaemia Working Party and Lymphoma Working Party of the EBMT.

Management of Relapsed/Refractory Hodgkin Lymphomas After ASCT in Czech Republic.

Patients with Mature T-Cell Lymphoma Show High Relapse Rates after High Dose Therapy and Autologous Stem Cell Transplantation

Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Benefit from the Newer Drugs Used in the Relapsed Setting.

Correlation of Cytokines Levels and Adhesion Molecules Expression with Stem Cell Mobilization Efficacy in Healthy Donors

The Reduced Intensity Cvd Regimen: A Good Option with Well Balanced Efficacy/Toxicity Ratio for Elderly Patients with Poor Status Performance

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

A Randomized Prospective Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors

A Prospective Study on the Feasibility of Related and Unrelated Donor Search and Hematopoietic Cell Transplantation for Adults with Acute Leukemia at 31 European Transplant Centers

Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.

Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only